TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Driven by its strategic goal to advance equity in the U.S. healthcare innovation sector, the American Medical Association (AMA) recently announced an initiative that supports leading industry stakeholders in committing to equitable health innovation opportunities targeted to improving health outcomes in historically marginalized communities. #Healthdisparities 

Surgical explantation after TAVR failure: What cardiologists, and patients, should know

Redo TAVR is not always a feasible treatment option, researchers explained. TAVR explantation can be offered to a larger patient population. 

September 23, 2021

Valve-in-valve TAVR a safe alternative for patients with failed bioprosthetic valves

The final decision between ViV TAVR and repeat SAVR, researchers said, should be based on multiple factors. 

September 21, 2021
heart.png

PCI before TAVR? New study provides answers, but questions remain

Researchers examined data from 17 different facilities, keeping a close eye on mortality and rehospitalization rates. 

September 20, 2021
approved approval safe

New TAVR system for high-risk patients gains FDA approval

The system was specifically designed for patients who should avoid open-heart surgery.  

September 20, 2021
artificial-intelligence-3382507_960_720.jpg

AI model classifies patients by aortic stenosis severity, could improve AVR timing

The classifier was developed using imaging data from nearly 2,000 patients. 

September 15, 2021
In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.

3 conditions associated with a higher stroke risk among TAVR patients

The new analysis, published in Current Problems in Cardiology, also explored the higher costs associated with post-TAVR stroke. 

September 2, 2021
Cardiologist heart

New meta-analysis examines valve durability after 5 years among TAVR, SAVR patients

As TAVR and SAVR patients get younger, valve durability will continue to gain more and more importance.

September 1, 2021
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.

Edoxaban comparable to VKAs for treating AFib after TAVR

Researchers shared their findings at ESC Congress 2021 and in the New England Journal of Medicine. 

August 31, 2021
Displaying 257 - 264 of 352

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup